Determinants of fatigue among adults with epilepsy: Should we focus solely on antiseizure medication effects?
Epilepsy & Behavior · 2025
DOI: 10.1016/j.yebeh.2025.110480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Kristijonas Puteikis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Fatigue, Epilepsy, Anticonvulsants. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Lietuvos Mokslo Taryba.
Abstract (Originalsprache)
INTRODUCTION: Fatigue is a frequent, albeit underexplored symptom among people with epilepsy (PWE). We aimed to investigate factors associated with fatigue among PWE with a special focus on antiseizure medication (ASM) use. METHODS: We conducted an anonymous cross-sectional survey among adult outpatients asking them to complete instruments assessing fatigue (the Fatigue Severity Scale, FSS), symptoms of anxiety (Generalized Anxiety Disorder-7, GAD-7), depression (Neurological Disorders Depression Inventory for Epilepsy, NDDI-E) as well as provide data on adverse ASM effects (Liverpool Adverse Events Profile, LAEP), medication type, number, adherence and self-reported treatment efficacy. Independent-samples t-test and Mann-Whitney U test (two groups) or analysis of variance and Kruskal-Wallis tests (more than two groups) were used for between-group comparisons. Correlation and linear multiple regression analysis was done in search of factors associated with fatigue. Multiple imputation was used for sensitivity analysis to account for missing data. RESULTS: The study sample comprised 232 PWE (130 (56.0 %) female, average age 39.1 ± 14.7 years) with 190 (81.9 %) PWE having completed the FSS and 40.5 % among them reporting clinically significant fatigue (FSS score ≥ 4). Higher FSS scores were associated with female sex (t = -2.086, p = 0.038), higher seizure frequency (r = 0.183, p = 0.020), missing at least one dose of ASMs in the past month (t = 2.491, p = 0.014), symptoms of anxiety (GAD-7, r = 0.510, p 0.05). FSS scores also did not differ across subgroups based on specific ASM use. Adverse ASM effects (LAEP), symptoms of anxiety (GAD-7) and the subjectively perceived efficacy of current treatment were independent factors associated with results of the FSS in a multiple regression model (F(3, 130) = 27.310, p < 0.001, Radj2 = 0.372). CONCLUSION: Our data suggests that fatigue among PWE is mostly associated with symptoms of anxiety, adverse ASM effects and self-reported treatment efficacy. Regardless of the type and count of ASMs, special attention to self-reported tolerability and efficacy, alongside psychological symptomatology, could help to reduce fatigue among PWE when adjusting treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Electronic address: ruta.mameniskiene@mf.vu.lt.
Förderung
- Lietuvos Mokslo Taryba
Zitieren
APA
Puteikis, K., Matuzevičius, B., & Mameniškienė, R. (2025). Determinants of fatigue among adults with epilepsy: Should we focus solely on antiseizure medication effects?. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110480
Vancouver
Puteikis K, Matuzevičius B, Mameniškienė R. Determinants of fatigue among adults with epilepsy: Should we focus solely on antiseizure medication effects?. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110480
BibTeX
@article{Puteikis2025,
author = {Puteikis, Kristijonas and Matuzevičius, Benas and Mameniškienė, Rūta},
title = {Determinants of fatigue among adults with epilepsy: Should we focus solely on antiseizure medication effects?},
journal = {Epilepsy & Behavior},
year = {2025},
doi = {10.1016/j.yebeh.2025.110480}
}
EUVIMED